NIH-funded research NIH-funded research

Drd3 gene variants and cocaine seeking in rats

Official title: Drd3 transcript variants and cocaine self-administration

Funded at Wake Forest University Health Sciences · NIH-11619073 · Data updated 2026-11-12

A study in rats will map different Drd3 gene variants to how cocaine-seeking and taking behavior is influenced, aiming to uncover targets for treating cocaine use disorder.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWake Forest University Health Sciences
NIH-funded
Lab location1 site (Winston-Salem, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2029
Funding year2026
Award (this year)$339,041
NIH project number4R33DA059919-03
Project IDNIH-11619073 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are patients with cocaine use disorder for future translation or trials related to Drd3-targeted therapies.

Less likely to help

Current patients will not receive direct treatment from this preclinical study, but findings may inform future therapies.

What this research studies

This project will explore how different forms of the dopamine D3 receptor gene (Drd3) affect cocaine-related behaviors in rat brains. Researchers will first use cell systems to understand what each Drd3 variant does, then create neuron-specific tools to express these variants in rats. In the later phase, they will test whether sex and brain region differences in these variants change cocaine seeking and taking, using targeted delivery methods. The work could identify specific receptor variants as future drug targets for cocaine use disorder.

Why it matters

Potential benefit: If successful, the findings could guide development of more precise therapies for cocaine use disorder by targeting Drd3 variants.

How similar studies have gone: Previous work links D3 receptor pathways to cocaine behaviors, and this study extends knowledge with variant-specific tools.

Where this research is happening

  • Wake Forest University Health Sciences
    Winston-Salem, United States
    Active

Researchers

  • Principal investigator: Chen, Rong — Wake Forest University Health Sciences
  • Study coordinator: Chen, Rong

Related research

Other NIH-funded projects on the same topics.

  • Evaluating a combined approach to manage chronic pain

    This study is looking at whether taking duloxetine along with online therapy can help people with chronic pain feel better, and it includes some support to help you stick with the therapy; you'll be randomly placed in one of three groups to see which approach works best over six months.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-9870024

  • Intensive dental care during cancer follow-up to protect teeth after head and neck radiation

    A program delivered in oncology clinics to provide fluoride varnish and dental follow-up aims to reduce tooth decay and improve oral health and quality of life for head and neck cancer patients after radiation therapy.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11575645

  • Wake Forest NCORP Cancer Center Research Base

    A patient-focused opportunity to advance real-world cancer care through community-based studies that address how cancer and its treatments affect daily life and well-being.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11543565

  • Hybrid approach to peer-supported mood and incentive program to reduce HIV risk among women who inject drugs

    A pilot program tests a combined peer-supported mood-boosting approach with contingency management to help stimulant-using women who inject drugs reduce HIV risk.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11537936

  • Coordinating Center for the MoTrPAC project

    A large nationwide effort seeks to map how physical activity changes the body at the molecular level, with a coordinating center that handles data, biospecimens, and collaboration across sites.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11537917

  • HeartShare HFpEF Clinical Center at Wake Forest

    A large, patient-centered program at Wake Forest to deeply profile people with HFpEF and healthy controls to uncover new disease mechanisms and treatment targets.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11528823

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.